ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,819.87
-0.39%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Twist Bioscience Corporation (TWST)

  7. Twist Bioscience Corporation (TWST) ニュース

TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TWST
日付受信時刻ニュースソース見出しコード企業名
2024/05/1321 : 00Business WireTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening ApplicationsNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0821 : 00Business WireTwist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0305 : 05Business WireTwist Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
2024/04/1821 : 00Business WireTwist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
2024/03/2821 : 00Business WireTwist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705 : 32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705 : 26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705 : 20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705 : 18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705 : 17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0522 : 00Business WireTwist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome SequencingNASDAQ:TWSTTwist Bioscience Corporation
2024/02/2222 : 00Business WireTwist Bioscience to Present at Upcoming Investor ConferencesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/1307 : 42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TWSTTwist Bioscience Corporation
2024/02/1006 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/1006 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0905 : 14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0806 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0722 : 00Business WireTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
2024/02/0706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
 Showing the most relevant articles for your search:NASDAQ:TWST

最近閲覧した銘柄

EU
LCWD
Amundi MSCI World V UCIT...
TG
NPG
Nippon El Glass
MRTX
PKOINBTC
Pocketcoin
ASX
CBAIO2
USOTC
NRUNF
Northern Uranium (CE)
COIN
XFEEUR
NASDAQ
MMZJX
Mass Mutual Select T Row...
NASDAQ
FXMKDX
S&P Target SMid 60 1Q 21...
NASDAQ
CDNA
CareDx
LATK
KTOETH
KRYPTORO Coin
COIN
DGMSBTC
ASX
EMEN
USOTC
NVLPF
Nova Leap Health (QX)
NASDAQ
FRWAU
PWP Forward Acquisition ...
USOTC
PLHNF
Paul Hartmann (CE)
LSE
0A9X
Kr1
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有